Dentsply Sirona Inc. (NASDAQ: XRAY), a leading manufacturer of professional dental products and technologies, reported fourth-quarter 2023 financial results, reporting an increase in net sales.
- Fourth-quarter net sales increased 2.9% year-over-year to $1.01 billion; organic sales moved up1.9%
- Net income, including special items, was $67 million or $0.32 per share in Q4, vs. a loss of $15 million or $0.07 per share a year earlier
- On an adjusted basis, the company reported earnings of $0.44 per share, down from the $0.46 per share it reported a year earlier
- For fiscal 2024, the company expects organic sales to be flat to up 1.5%; adjusted EPS is expected to be between $2.00 and $2.10
- The board of directors approved a 14% increase in the company’s quarterly dividend rate, from the previous rate of $0.14 per share
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
